Research Report: HIMS

Analysis Date: 2025-12-11T23:00:59.205718 Trading Period: 2025-12-08 to 2025-12-19

Company Overview

Company: Hims & Hers Health, Inc. Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic Current Price: $37.77 Market Cap: $8,598,284,288 Beta: 2.41 Avg Volume: 26,553,403 P/E Ratio: 71.26 Website: https://www.hims.com

Description: Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over...

Trading Recommendation

Action: AVOID Confidence: 45.0/100 Position Size: 0.0% of portfolio

Rationale: Unfavorable conditions (composite: 45.0/100, risk: LOW, red flags: 1).

Key Risks:

Screening Status

Passed Filters: ✓ Yes Notes: Passed all screening filters

Quantitative Analysis

Composite Score: 2.80/5.0 Percentile Rank: 50%

Factor Scores:

Technical Analysis

Setup Score: 1/8 Setup Notes: In uptrend

Price Levels:

Momentum & Volume:

Risk Assessment

Risk Level: LOW Confidence: 70.0/100 Total Red Flags: 1 Earnings Risk: No

Stock-Specific Red Flags:


This report is generated by PM automated research system. Always perform your own due diligence before trading.